CHAPTER FIVE 5.1 DISCUSSION
5.2 CONCLUSION AND RECOMMENDATION
Malaria ranks among the major health problems facing many developing countries, notably in Sub-Saharan Africa. Fighting malaria requires significant financial and organizational resources.
While Malaria continues to be a problem, it is likely that anti disease Malaria vaccine will become available in the foreseeable future, lessons from the past suggests that lack of acceptance and support from the intended recipients may lead to less than optimal compliance, and hence efficacy. For the planning of Vaccine development and application strategies, it is therefore, highly important to take community views into account. Here it is argued that such information could help researchers and funding agencies to set priorities for future vaccine research.
However, this is the first time this study is done in my country as a result household heads and patients were not supportive because some of them were reluctant to reveal their socio economic status. There was also no fund for the research as a result there was a transportation problem to go to the study site.
A similar study should also be done in the Southern part of the Gambia (rural areas) to see the real effects of the Willingness to pay (WTP) especially for the household heads with many wives hence it is in the rural area the household heads practice polygamy in most cases. Although the result clearly points out that those that have fewer children were WTP more than those with large family.
REFERENCES
Andreano, R., & Helminiak, T. (1998). Economic, Health and Tropical Disease; A review in Economics, Health and Tropical Disease. University of Philippines School of economics.
Asante, F. A., & Okyere, K. A. (2003 ). Economic burden of malaria in Ghana. A technical report submitted to the World Health Organization, African Regional Office. Institute of Statistical, Social and Economic Research, University of Ghana, Legon.
Brandt, H. (1980). Work capacity constraints in tropical agricultural development. Frankfurt, Verlag Peter Lang.
Brown, D.S., Johnson, F.R., Paulos,C., & Messonnier, M.L. (2009). Mothers‟ preference and willingness to pay for vaccinating daughters against human Papillomavirus. Centers for Disease Control and Prevention. Doi:10.1016/j.vaccine.2009.12.024.
Carlsson, K.S., Hojgard,S., Lethagen,S., Lindgren, A.,Berntorp, E., &Lindgren,B.
(2004).Willingness to pay for on demand and Prophylactic Treatment for severe Haemophilia in Sweden. Journal of Haemophilia ,10,527-541.doi:10.1111/j.1365-2516.2004.00954.x.
Carson, R. T. (1999). Contingent Valuation: A User‟s Guide. Department of Economics, University of California San Diego (UCSD), University of California (UC) San Diego.
Catholic Relief Services, The Gambia (2007). Safety nets against malaria. Retrieved May from http:crs.org/the-gambia/malaria-nets/.
Creese, A., & Parker, D. (1994). Cost analysis in primary health care; A training manual for program managers. WHO, Geneva. Retrieve May 2010 from
http://www.who.int/immunization_financing/data/methods/en/caphc_creese.pdf.
Cunningham, K. (2010). Cost of illness handbook. National service centre for environmental publications (NSCEP) United States .Retrieved from
http//www.epa.gov/opt/coi/pubs/1_1.pdf.
- 85 -
Davis, C., Shiel W.C Jr. (2011). Malaria symptoms, treatment, cycle, prevention in children and during pregnancy) retrieved April 10 2010 from
http://www.medicinenet.com/malaria/article.htm
Dong. H., Kouyate, B., Snow, R., Mugisha, F., Sauerborn, R. (2003). Genders effects on Willingness to pay for community based insurance in Burkina Faso. Journal of health policy, 64,153-62.
Dranitsaris, G., Elia-Pacitti, J., & Cottrell, W. (2004). Measuring treatment preferences and willingness to pay for Doxcetaxel in Advanced Ovarian Cancer. Journal of Pharmacoeconomics, 22, 375-387.
Gallup, J.L., &Sachs, J.D.(1999). Malaria climate and poverty. Institute for International Development. Retrieved from
http//www.cid.harvard.edu/caer2/htm/content/papers/paper48/paper48.htm.
Gallup, J.L., & Sachs, J. D. (2001). The economic burden of malaria. American Journal of Tropical Medicine and Hygiene, 64, 85-96.
Grutters, J.P.C., Anteunis,L.J.C., Chenault,M.N., & Joore, M.A.(2009). Willingness to pay for a hearing aid: Comparing the payment scale and open ended question. Journal of evaluation and clinical practice. doi:10.1111/j.1365-2753.2008.00959.x
Haghdoost, A.A., Alexander, N., & Smith, T. (2007).Maternal Malaria during pregnancy and Infant Motality rate: Critical Literature review and a new analytical approach. Journal of Vector Borne Disease, 44, 98-104.
Harwood, H.J.(1994).Analytical principles and issues in making cost of illness estimates for substance Abuse. Journal of Environmental Economics and Management. CCSA, Canada.
Hodgson ,T.A. & Meiners, M.R.( 1992). Cost of illness: A guide to current practices and procedures. Milbank Memorial Fund Quarterly Health Society, 60,429-62.
Hunt,T.L., Luce, B,R., Page, M.J., & Pokrzywinski, R.(2009).Willingness to pay for Cancer Prevention. Journal of Pharmacoeconomics, 27,299-312.
Kamal,F.M., Hadi,A. M., Chowdhury R. A. (1995). Differential of the immunization programme in rural Bangladesh and the issue of user free. Regional Health forum World Health Organization South East Asian Region. Retrieved from:
http://www.searo.who.int/en/section
Keiji,H., Toshinori,N., Ichiro,W., Kentaro,Y., Shinji,S., Masahiro,A., et al (2006). How great is willingness to pay for recovery from sequelae after severe traumatic brain injury in Japan? Journal of Rehabilitation Medicine.38.141-143
Kim.D.,Canh.G.D.,Poulos.C.,Thoa.K.T.L.,Cook.J.,Hoa.T.N.,et al(2008). Private demand for cholera vaccines in Hue, Vietnam. Journal of Value of health.11.1-11.
Lisa, A., Thomas Ray, G., O‟Brien, M., Kleinman, K., Santoli, J., & Lieu, T.A. (2004).
Preference and willingness to pay for health state prevented by Pneumococcal Conjugate Vaccine. Journal of Pedriatrics, 113, 283-290.
Liu,J.T., Hammitt,J.K.,Wang,J.D.,Liu, J.L. (2000).Mother‟s willingness to pay for her own and her child‟s health: A contingent valuation study in Taiwan. Journal of health economics, 9,319-326.
Lundberg, L., Johannesson, M., Silverdahl, M., Hermansson, C., & Lindberg, M. (1999). Quality of life, health state utilities and willingness to pay in patients with psoriasis and atopic eczema. British Journal of Dermatology,141, 1067-1075.
Masiye, F., Rehnberg,C.(2005).The economic value of an improved malaria treatment program in Zambia: Result from a contingent valuation method. Malaria
journal.4.doi:10.1186/1475-2875-4-60
McCarthy, D.F., Wolf, H., & Wu, Y. (2000). The growth costs of malaria. World Bank report Georgetown University and NBER.McDonald, G. (1950). The economic importance of Malaria in Africa. World Health Organization. WHO/MAL/60, AFR/MAL/conf./16.
http://siteresources.worldbank.org/INTMALARIA/Resources/377501-1114188195065/WBMalaria-GlobalStrategyandBoosterProgram-References.pdf
- 87 -
Mills, A. (1992). The economics of malaria control, “in G. Targett (ed.) malaria: Waiting for vaccine. Chichester: John Wily and Sons.
Mills, A. (1998). Operational research on the economics of insecticide-treated mosquito nets:
lessons of experience. Journal of Annals of Tropical medicine and Parasitology, 92, 435-7.
National Malaria Control Program (2008). Malaria control in The Gambia
Onwujekwe,O., Chima,R., Shu,E., Nwagbo,D., & Okonkwo, P. (2001).Hypothetical and actual willingness to pay for insecticide treated nets in five Nigerian communities. Journal Tropical Medicine and International Health, 6,545-553.
Pia, M. (2003). Micro-economics approaches to evaluating the burden of Malaria. Centre for International Development (CID) working paper No. 99. Harvard Retrieve from
http://www.hks.harvard.edu/var/ezp_site/storage/fckeditor/file/pdfs/centers-programs/centers/cid/publications/faculty/wp/099.pdf
Pluess B., Tanser FC., lengeler, C., Sharp, B.L. (2010).Indoor residual spraying for preventing malaria. Cochrane Database of
SystematiReviews.4:Doi:10.1002/14651858.CD006657.pub2.
Prescott, N.M. (1999). The economics of Schistosomiasis and development. World Development Retrieved May 22, 2010, From Wikipedia, http://en.wikipedia.org/wiki/bjl.
Sachs, J.,& Malaney, P. (2002). The economic and social burden of Malaria. Journal of Nature, 415, 680-685.
Sachs, J., & Malaney, P. (2002). The Economic and Social Burden of malaria. Centre for Disease Control and Prevention . Journal of Nature, 415, 680-85.
Sam,I.C., Wong, L.P., Rampal, S., Leong,Y,H., Fu- Pang,C., Tai, Y.T., Tee,H.C., & Kahar Bador,M. (2009). Maternal acceptance of Human Papillomavirus vaccine in Malaysia.
Journal of Adolescent Health,44,610-612.
Sauerborn, R., Gbangou, A., Dong, H., Przyborski, M. J., & lanzer, M. (2005). Willingness to pay for hypothetical vaccine in rural Burkina Faso. Scandinavian Journal of public health, 33, 146-150. doi: 10.1080/14034940510005743.
Saulo, C. E., Forsberg, C. B., Premji, Z., Montgomery, M. S., & Bjorkman, K.
(2008).Willingness and ability to pay for artemisinin based combination therapy in rural Tanzania. Malaria journal,7, 227. doi: 10.1186/1475-2875-7-227.
Shepard, D.S., Ettling, M.B., Brinkmann, U., & Sauerborn, R. (1991).The economic cost of malaria in Africa. Journal of Tropical Medicine and Parasitology, 42, 199-203.
Single, E., Collins, D., Easton, B., Harwood, H., lapsley, H., Kopp, P., et al.(2001). International guidelines for estimating the cost of substance abuse. Retrieved from
www.ccsa.ca/costs/Guidelines/intguide.htm.
Streeten, P., (1981). First thing first; meeting basic human needs in development countries. New York, Oxford University Press.
Tang, C.H., Liu, J.T., Pwu, R.F., You, S.L., Chow, L., &Tang, C.H P.(2009).Valuation of the economic benefits of Human Papillomavirus (HPV) Vaccine in Taiwan. Value in Health, 12, 1-5.
Udezi, W.A., Usifoh, C.O., Ihimekpen, O.O. (2010).Willingness to pay for three hypothetical Malaria vaccines in Nigeria. Journal of Clinical Therapeutics, 32,1533-44.
Wernsdofer, W.H., & McGregor, S., I. (1998). Malaria principles and practice of Malariology.
Churchill Livingstone, New York.2. 1-26.
World Malaria Report. (2005). World Health Organization Retrieved from WHO Library Cataloguing in Publication Data. WHO/HTM/MAL/2005.1102
http://whqlibdoc.who.int/publications/2005/9241593199_eng.pdf
World Malaria Report (2009). Retrieved from http://www.who.int/malaria/world _malaria_report_2009/en/index.htm
World Health Organization (1997). World malaria situation in 1994, part 1, WHO weekly Epidemiological record ,36,269-274. http://pdf.usaid.gov/pdf_docs/PNACH805.pdf World Health Organization .(1999). World Health Report, 1999, making a difference. Retrieved
from http:/www.who.int/whr/1999/.
World Health Organization. (2002). Macroeconomics and health initiative in Accra. Press release No.013/02 Retrieved from
.http/www.who/int/macrohealth/infocentre/press/bulletin/en/html.
- 89 -
World Health Organization /UNICEF. (2003). Africa Malaria Report. WHO/CDS/MAL/2003.
1093.2003 Geneva. Retrieved from
http://www.rollbackmalaria.org/wmr2005/html/references.htm
World Bank. (1993). Investing in health. World Development Report 1991. Washington. Oxford University Press. http://www.jstor.org/pss/1154434
Yasunaga, H. (2008).Willingness to pay for mass screening for prostate cancer: A contingent Valuation Survey. International Journal of Urology,15,102-105.doi:10.1111/j.1442-2042.2007.01931.x, 10.1111/j.1442-2042.2007.01986.x.